Clinical DNA Extraction Kit for Oncology

Technical Specifications

Working Principle

The kit operates on principles such as cell lysis to break open cells and release DNA, followed by binding to a solid phase like silica membranes or magnetic beads to separate DNA from impurities. Washing steps remove proteins and other contaminants, and finally, the pure DNA is eluted in a buffer. This process ensures the isolation of intact DNA, which is critical for downstream analyses in cancer diagnostics and research.

Performance

The kit delivers consistent and high yields of pure DNA, crucial for sensitive applications like PCR and sequencing in oncology studies. It minimizes contamination and degradation, ensuring that the extracted DNA is suitable for detecting low-frequency mutations often present in cancer cells. This reliability supports accurate diagnostic results, which are vital for developing effective cancer therapies and monitoring patient responses over time.

Application

This kit is widely used in clinical oncology for extracting DNA from various sample types, including tumor tissues, blood, and biopsies. It facilitates genetic testing for cancer biomarkers, aiding in early detection, prognosis assessment, and treatment selection. Additionally, it supports research in molecular oncology, helping scientists study genetic alterations that drive cancer development and identify potential targets for new drugs.

Core Features and Advantages

Key features include high sensitivity for low-abundance DNA, compatibility with automated systems for high-throughput processing, and user-friendly protocols that reduce hands-on time. Advantages encompass rapid extraction times, minimal sample requirements, and high reproducibility, making it ideal for busy clinical labs. These aspects enhance efficiency and accuracy in oncology workflows, supporting better patient outcomes through reliable genetic data.